J Sieper Selected Research

Sulfasalazine (Azulfidine)

7/2011	Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48.
4/2011	Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial.
1/2010	Analysis of uveitis rates across all etanercept ankylosing spondylitis clinical trials.
11/2006	[Spondylarthritides].
9/2006	Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial.
3/2006	First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis.
9/2004	Biological therapies in the spondyloarthritides--the current state.
9/2003	International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis.
4/2002	[New and old therapeutic options in ankylosing spondylitis--is there an indication for sulfasalazine?].
1/2002	Co-occurrence of spondyloarthropathy and connective tissue disease: development of Sjögren's syndrome and mixed connective tissue disease (MCTD) in a patient with ankylosing spondylitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Sieper Research Topics

Disease

85	Ankylosing Spondylitis 01/2019 - 02/2000
30	Necrosis 03/2016 - 04/2000
20	Axial Spondyloarthritis 11/2019 - 06/2009
18	Arthritis (Polyarthritis) 01/2011 - 01/2000
14	Inflammation (Inflammations) 01/2015 - 01/2000
14	Rheumatoid Arthritis 06/2014 - 04/2000
13	Psoriatic Arthritis 03/2016 - 02/2000
11	Back Pain (Backache) 01/2011 - 01/2000
8	Rheumatic Diseases (Rheumatism) 03/2016 - 11/2007
8	Pain (Aches) 07/2010 - 06/2003
8	Reactive Arthritis (Reiter Disease) 04/2003 - 01/2000
8	Spondylarthropathies 12/2002 - 04/2000
7	Sacroiliitis 01/2011 - 01/2000
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2011 - 07/2001
5	Ankylosis 07/2011 - 01/2000
4	Infections 01/2017 - 09/2000
4	Crohn Disease (Crohn's Disease) 01/2017 - 07/2001
4	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2014 - 05/2004
3	Spondylarthritis (Spinal Arthritis) 02/2020 - 06/2003
3	Uveitis 01/2016 - 01/2010
3	Osteoarthritis 01/2015 - 11/2000
3	Non-Radiographic Axial Spondyloarthritis 11/2014 - 07/2010
3	Anterior Uveitis 07/2010 - 05/2004
3	Body Weight (Weight, Body) 03/2008 - 04/2003
3	Osteoporosis 07/2001 - 04/2001
2	Fatigue 01/2017 - 12/2004
2	Chronic Disease (Chronic Diseases) 01/2017 - 03/2010
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 06/2014 - 01/2002
2	Myocarditis (Carditis) 01/2002 - 06/2000
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Neoplasms (Cancer) 01/2017
1	Joint Diseases (Joint Disease) 01/2012
1	Hypersensitivity (Allergy) 07/2011
1	Iritis 01/2010
1	Iridocyclitis 01/2010
1	Ulcerative Colitis 05/2007
1	Injection Site Reaction 12/2004

Drug/Important Bio-Agent (IBA)

33	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 04/2000
27	Infliximab (Remicade)FDA Link 01/2016 - 06/2000
16	Etanercept (Enbrel)FDA Link 07/2011 - 07/2001
11	Biological ProductsIBA 01/2019 - 07/2001
11	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019 - 01/2000
11	CytokinesIBA 01/2015 - 04/2000
10	Sulfasalazine (Azulfidine)FDA LinkGeneric 07/2011 - 01/2002
9	C-Reactive ProteinIBA 01/2017 - 06/2003
8	Tumor Necrosis Factor InhibitorsIBA 02/2020 - 09/2004
8	HLA-B27 Antigen (HLA B27 Antigen)IBA 06/2011 - 04/2000
7	Antirheumatic Agents (DMARD)IBA 01/2012 - 11/2002
7	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 07/2010 - 01/2000
6	AntigensIBA 01/2011 - 04/2000
6	Interferon-gamma (Interferon, gamma)IBA 11/2008 - 04/2000
5	Certolizumab Pegol FDA Link 01/2016 - 01/2014
5	Proteins (Proteins, Gene)FDA Link 06/2014 - 07/2003
5	Methotrexate (Mexate)FDA LinkGeneric 09/2010 - 04/2000
5	Interleukin-10 (Interleukin 10)IBA 06/2006 - 04/2000
5	Monoclonal AntibodiesIBA 05/2005 - 06/2000
4	Pharmaceutical PreparationsIBA 11/2019 - 01/2002
4	AntibodiesIBA 01/2016 - 09/2000
4	SteroidsIBA 03/2006 - 04/2001
4	Gadolinium DTPA (Magnevist)FDA Link 05/2005 - 02/2000
3	InterleukinsIBA 01/2015 - 06/2002
3	Adalimumab (Humira)FDA Link 08/2013 - 05/2005
3	Interleukin-4 (Interleukin 4)IBA 07/2003 - 04/2000
3	Anti-Bacterial Agents (Antibiotics)IBA 04/2003 - 04/2000
2	secukinumabIBA 01/2019 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2015 - 06/2006
2	AutoantibodiesIBA 06/2014 - 01/2002
2	AutoantigensIBA 06/2014 - 07/2003
2	Naproxen (Naprosyn)FDA LinkGeneric 01/2014 - 01/2014
2	Prednisolone (Predate)FDA LinkGeneric 01/2014 - 01/2002
2	Therapeutic UsesIBA 03/2007 - 02/2005
2	Aligeron (AS 2)IBA 12/2006 - 08/2005
2	Aggrecans (Aggrecan)IBA 05/2005 - 07/2003
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 02/2005 - 11/2000
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 12/2004 - 09/2003
2	GlucocorticoidsIBA 07/2001 - 04/2001
1	golimumab FDA Link 10/2015
1	Biomarkers (Surrogate Marker)IBA 06/2012
1	N 30IBA 07/2011
1	Histocompatibility Antigens Class IIBA 06/2011
1	Abatacept (Orencia)FDA Link 06/2011
1	Rituximab (Mabthera)FDA Link 05/2010
1	Virulence Factors (Pathogenicity Factors)IBA 11/2008
1	Diclofenac (SR 38)FDA LinkGeneric 03/2008
1	Celecoxib (Celebrex)FDA Link 03/2008
1	ParaffinIBA 06/2006
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 06/2006
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2006
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 12/2005
1	Interleukin-1 (Interleukin 1)IBA 02/2005
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 02/2005
1	Leflunomide (Arava)FDA LinkGeneric 01/2005

Therapy/Procedure

41	Therapeutics 11/2019 - 04/2000
2	Contraindications 03/2006 - 09/2003
2	Biological Therapy 05/2005 - 09/2003
1	Drug Tapering 01/2016
1	Retreatment 08/2013
1	Secondary Prevention 01/2012
1	Subcutaneous Injections 03/2007
1	Withholding Treatment 02/2006